Josh Galdi, PharmD, BCPS and Hannah N. Lambert, PharmD discuss the current understanding of IgA nephropathy with Anor Shaw, MD. They explore the nature of this common glomerular…
This video discusses the management of IgA nephropathy, a common and incurable kidney disease. Treatment aims to control the disease and delay kidney damage progression. Lifestyle changes, such…
Professor John Barrett, a renowned nephrologist from the University of Leicester, discusses the latest advancements in the treatment of IgA nephropathy. Filmed at the 61st ERA Conference in…
Emma, a person who has IgA nephropathy, discusses her experience with diagnosis and treatment. She also discusses the importance of communication with medical professionals and she recommends avoiding…
Clarissa Tio, MD, a nephrologist at the University of Mississippi, moderates a discussion between Ariana Barton, a patient living with IgA nephropathy and a patient advocate, Joshua Samuels,…
Jonathan Barratt, MD, consultant nephrologist and professor of renal medicine, University of Leicester and John Walls Renal Unit, Leicester, provides a comprehensive overview of IgA nephropathy. Prof Barratt…
Dr. Richard Lafayette, founder and director of the Glomerular Disease Center at Stanford University Medical Center, discusses the prevalence and impact of IgA nephropathy, the most common primary…
This video provides a comprehensive overview of IgA nephropathy. The condition involves the deposition of the antibody IgA in the kidneys, which can lead to kidney damage. The…
This video discusses IgA nephropathy (IgAN), a kidney disease where proteins from the immune system build up in the kidney filters, causing inflammation and potential damage. It details…
The CARE1 pragmatic clinical trial was designed to determine the optimal treatment combination for patients with metastatic kidney cancer, using a specific biomarker. The trial, funded by the…